Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Disease area: Airway diseases

Abstract

Introduction: The assessment of pulmonary function and the maximal ventilatory pressures have been of great clinical importance, besides having great potential for the diagnosis and prognosis of lung diseases. Due to airflow obstruction, irreversible dilatation of the bronchi and bronchioles, and the presence of secretion individuals with bronchiectasis (BCTS) may show changes in their respiratory muscles and lung capacity, leading to impact on your quality of life health related. Objective: To assess the pulmonary function and the maximum ventilatory pressure in subjects with BCTS. Method: This is an observational and cross-sectional study that assessed 21 patients with a previous diagnosis of BCTS, at Respiratory Physiology laboratory of Nove de Julho University (UNINOVE) in the city of Sao Paulo- Brazil. The evaluation consisted of medical history, vital signs, anthropometry, spirometry and manovacuometry. Results: The mean age was 51.57±15.11 years, (57.1% female) and body mass index of 23.93 ± 3.75 kg/m2. There was a predominance of obstructive lung disease (52.4%) and reductions in the mean spirometric values of predicted (FVC, FEV1 and FEV1/FVC were 2.45 ± 0.87, 1.63 ± 0.76 and 66.49 ± 15.26 respectively). The mean values of maximal inspiratory pressures for females were 70.16 ± 26.60 and 95.55 ± 22.92 for males. The maximum expiratory pressures were 63.66 ± 24.34 and 105.11 ± 23.85 respectively for females and males. Conclusion: Patients with BCTS presented a predominance of obstructive lung disease, reductions in spirometric values and maximal ventilatory pressures, either with regard to gender or etiology of BCTS compared with Brazilian population.

Rating:

Share or cite this content

Citations should be made in the following way:
N. S. Faria Júnior, R. K. Palma, I. D. R. Santos, N. T. Fonseca, J. J. Urbano, I. S. Dias, A. M. Bigatao, S. R. Santos, F. S. S. Leitão Filho, J. R. Jardim, L. V. F. Oliveira (Belo Horizonte, Sao Paulo, Fortaleza, Brazil). Maximal ventilatory pressure and pulmonary function in subjects with non-cystic fibrosis bronchiectasis. Eur Respir J 2014; 44: Suppl. 58, 2564

Member's Comments

No comment yet.

Related content which might interest you: Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Changes in pulmonary function tests following antibiotics in infants with pulmonary exacerbation of cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Pulmonary function of infants with cystic fibrosis, with and without respiratory symptoms Source: Eur Respir J 2002; 20: Suppl. 38, 529s Year: 2002 Relationship the impulse oscillometry parameters and the lung damage in idiopathic pulmonary fibrosis patients Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation Year: 2013 Pulmonary hemodynamics and lung function in patients with COPD and DPLD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Pulmonary function and respiratory muscular strength in end-stage renal disease patients under hemodialysis Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Short-term effect of autogenic drainage on ventilation inhomogeneity in adults with stable non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient Year: 2016 Tracking pulmonary exacerbations in preschool children using the lung clearance index Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Lung clearance index and exercise capacity among children with CF and non-CF bronchiectasis over a two year period Source: International Congress 2015 – Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease Year: 2015 Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Impulse oscillation respiratory reactance and airway reversibility in chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Induced sputum and respiratory function in pulmonary fybrosis Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003 Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS) Source: International Congress 2014 – Innovative technology and techniques in respiratory function Year: 2014 Continuos positive airway pressure by helmet in exacerbation of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Mechanical ventilation and weaning Year: 2013 Small airways dysfunction in chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – Dyspnoea and respiratory muscle mechanics dysfunction in disease Year: 2015 Relationship between pulmonary function tests and exercise performance in patients with alveolar proteinosis Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Pseudo hyperinflation of lung in patients with achalasia Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016